KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Cash from Operations (2016 - 2026)

Abbott Laboratories' Cash from Operations history spans 18 years, with the latest figure at 1315000000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 7.2% to 1315000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 9464000000.0, a 5.74% increase, with the full-year FY2025 number at 9566000000.0, up 11.78% from a year prior.
  • Cash from Operations hit 1315000000.0 in Q1 2026 for Abbott Laboratories, down from 3315000000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for ABT hit a ceiling of 3315000000.0 in Q4 2025 and a floor of 1025000000.0 in Q1 2024.
  • Historically, Cash from Operations has averaged 2134176470.59 across 5 years, with a median of 2065000000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: crashed 50.08% in 2023 and later skyrocketed 62.93% in 2024.
  • Tracing ABT's Cash from Operations over 5 years: stood at 2326000000.0 in 2022, then skyrocketed by 30.61% to 3038000000.0 in 2023, then fell by 5.6% to 2868000000.0 in 2024, then increased by 15.59% to 3315000000.0 in 2025, then tumbled by 60.33% to 1315000000.0 in 2026.
  • Business Quant data shows Cash from Operations for ABT at 1315000000.0 in Q1 2026, 3315000000.0 in Q4 2025, and 2787000000.0 in Q3 2025.